Skip to content

ADIL — Adial Pharmaceuticals Inc Institutional Holders · Q2 2026

Who owns Adial Pharmaceuticals Inc (ADIL)? 18 institutions reported holding $334,555 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Jane Street Group, LLC ($82,225), Citadel Advisors LLC ($75,640), UBS Group AG ($49,017).

RankInstitutionValueSharesChange
1JANE STREET GROUP, LLC$82,22532,119New
2CITADEL ADVISORS LLC$75,64029,547New
3UBS Group AG$49,01719,147Added
4StoneX Group Inc.$35,67119,699New
5GEODE CAPITAL MANAGEMENT, LLC$31,72512,393Trimmed
6VANGUARD GROUP INC$29,97711,710Added
7China Universal Asset Management Co., Ltd.$20,4808,000New
8Manchester Capital Management LLC$4,9231,923Hold
9Tower Research Capital LLC (TRC)$3,6331,419Added
10BlackRock, Inc.$778304Trimmed
11RAFFA WEALTH MANAGEMENT, LLC$21283Hold
12MORGAN STANLEY$12850Hold
13SBI Securities Co., Ltd.$12047Hold
14WELLS FARGO & COMPANY/MN$156Hold
15HARBOUR INVESTMENTS, INC.$83Hold
16Abound Wealth Management$31Hold
17NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$00Exited
18Caitong International Asset Management Co., Ltd$00Exited

Source: SEC Form 13F filings · as of 2026-06-30